Oct 2024 – On the basis of her R01 application, she received a seven-year Early Stage Investigator Merit award from NIH/NIDA. This reflects the esteem with which she is held by NIDA leadership.

Oct 2024 – Congratulations to Immaculeta (Zimmermann lab) for her NIH F31 Predoctoral Fellowship Pathophysiological impact of subtypes of eosinophil cell death.

Oct 2024 – James was awarded fourth place in this year's Graduate Student Poster Symposium (years 1 to 3).

Oct 2024 – For his entry in this year's Graduate Student Poster Symposium (years 1 to 3), Olukunle (Quattrocelli lab) was awarded fifth place.

Oct 2024 – Corbin (Kalfa lab) was awarded fourth place in this year's Graduate Student Poster Symposium (years 4 and up).

Oct 2024 – Immaculeta (Zimmermann lab) has received a Pharmacology Professional Development Award to attend the annual meeting of the American Heart Association.

Congratulations to PhD student Elizabeth Mancz!

Oct 2024 – Elizabeth (Sah lab) has received a Pharmacology Professional Development Award to attend the annual meeting of the Pavlovian Society.

Oct 2024 – James (Chella Krishnan lab) has received a Kline Physiology Professional Development Award to attend the Keystone Symposia conference "Trajectories to Heart Failure: Immunometabolic Mechanisms".

Dr. Ulrich-Lai and colleagues publish in "Pain"

Oct 2024 – Dr. Ulrich-Lai joined a group describing the Sex-specific role of RNA-binding protein, pAUF1, on prolonged hypersensitivity after repetitive ischemia with reperfusion injury.

Oct 2024 – Dr. Gao (as first author) and her colleagues discuss TRAF7: a new member of the E3 ligase family in cardiac hypertrophy.

Oct 2024 – The authors (Dr. Kirley pictured) report Decreased solubility and increased adsorptivity of a biotinylated humanized anti-cocaine mAb.

Oct 2024 – The group describes a GenePHIT phase 2 study design: a double blind, placebo-controlled trial to assess efficacy, safety, and tolerability of AB-1002 gene therapy in adults with heart failure.